Subthalamic nucleus deep brain stimulation in primary Meige syndrome: motor and non‐motor outcomes
European Journal of Neurology · 2024
DOI: 10.1111/ene.16121 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Qing-Pei Hao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Subthalamic Nucleus, Meige Syndrome, Dystonia, Deep Brain Stimulation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Municipal Health Commission, Peking University People's Hospital.
Abstract (Originalsprache)
Background and purpose Deep brain stimulation (DBS) has emerged as a promising treatment for movement disorders. This prospective study aims to evaluate the effects of bilateral subthalamic nucleus DBS (STN‐DBS) on motor and non‐motor symptoms in patients with primary Meige syndrome.
Methods
Thirty patients who underwent bilateral STN‐DBS between April 2017 and June 2020 were included. Standardized and validated scales were utilized to assess the severity of dystonia, health‐related quality of life, sleep, cognitive function and mental status at baseline and at 1 year and 3 years after neurostimulation.
Results
The Burke−Fahn−Marsden Dystonia Rating Scale movement scores showed a mean improvement of 63.0% and 66.8% at 1 year and 3 years, respectively, after neurostimulation. Similarly, the Burke−Fahn−Marsden Dystonia Rating Scale disability scores improved by 60.8% and 63.3% at the same time points. Postoperative quality of life demonstrated a significant and sustained improvement throughout the follow‐up period. However, cognitive function, mental status, sleep quality and other neuropsychological functions did not change after 3 years of neurostimulation. Eight adverse events occurred in six patients, but no deaths or permanent sequelae were reported.
Conclusions
Bilateral STN‐DBS is a safe and effective alternative treatment for primary Meige syndrome, leading to improvements in motor function and quality of life. Nevertheless, it did not yield significant amelioration in cognitive, mental, sleep status and other neuropsychological functions after 3 years of neurostimulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Peking University People's Hospital, Beijing, China.
- Department of Neurology, Peking University People's Hospital, Beijing, China.
- Functional Neurosurgery Research Center, Peking University Health Science Center, Beijing, China.
- Department of Neuropsychology, Peking University People's Hospital, Beijing, China.
- Department of Neurosurgery, Beijing Shunyi Hospital, Beijing, China.
ORCID-Profile: Qing-Pei Hao, Wen-Tao Zheng, Ru-En Liu
Förderung
- Beijing Municipal Health Commission
- Peking University People's Hospital
Zitieren
APA
Hao, Q. P., Zheng, W. T., Zhang, Z. H., Liu, Y. Z., Ding, H., OuYang, J., Liu, Z., Wu, G. Y., & Liu, R. E. (2024). Subthalamic nucleus deep brain stimulation in primary Meige syndrome: motor and non‐motor outcomes. European Journal of Neurology. https://doi.org/10.1111/ene.16121
Vancouver
Hao QP, Zheng WT, Zhang ZH, Liu YZ, Ding H, OuYang J, et al. Subthalamic nucleus deep brain stimulation in primary Meige syndrome: motor and non‐motor outcomes. European Journal of Neurology. 2024. doi:10.1111/ene.16121
BibTeX
@article{Hao2024,
author = {Hao, Qing-Pei and Zheng, Wen-Tao and Zhang, Zi-Hao and Liu, Ye-Zu and Ding, Hu and OuYang, Jia and Liu, Zhi and Wu, Guang-Yong and Liu, Ru-En},
title = {Subthalamic nucleus deep brain stimulation in primary Meige syndrome: motor and non‐motor outcomes},
journal = {European Journal of Neurology},
year = {2024},
doi = {10.1111/ene.16121}
}
EUVIMED